50% off all subscriptions! ... left. Order NowOrder Now

$0.52 (0%)

Volume: 57

Closed: Nov 26, 2021

Hollow Logo Score: -3.612

Acura Pharmaceuticals Stock Forecast

$0.52 (0%)

Volume: 57

Closed: Nov 26, 2021

Score Hollow Logo -3.612
Which way will ACUR go? Request
Key Stats
P/E Ratio -29.41
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 39 and the stock is currently not being overbought or oversold

Red day on Friday for Acura Pharmaceuticals
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-26

No changes to the price of Acura Pharmaceuticals stock on the last trading day (Friday, 26th Nov 2021). During the day the stock fluctuated 0% from a day low at $0.52 to a day high of $0.52. The price has been going up and down for this period, and there has been a -6.73% loss for the last 2 weeks.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Acura Pharmaceuticals stock with a 90% probability to be traded between $0.48 and $0.58 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Signals & Forecast

There are few to no technical positive signals at the moment. The Acura Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.53 and $0.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 23, 2021, and so far it has fallen -11.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, October 06, 2021 and based on theory for this formation the price should go up by 3.13% to $0.54 within 8 trading days since signal was issued (Monday, October 18, 2021).

Support, Risk & Stop-loss

Acura Pharmaceuticals finds support from accumulated volume at $0.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 4.72%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Acura Pharmaceuticals stock A Buy?

Acura Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.612

Predicted Opening Price for Acura Pharmaceuticals of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$0.52 $0.52 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 4.72 %
Overall Risk: Very High High Medium Low Very Low
4.72 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.54
Price: $0.52
Support: $0.52

ACUR Insider Trading Show all Trades



Last 100 transactions
Buy: 99 268 128 | Sell: 7 967 278 (Shares)
Date Action Amount Person Type
Jun 09, 2021 Sell 6 877 500 Abuse Deterrent Pharma, Llc Convertible Promissory Note
Jun 09, 2021 Buy 42 984 375 Abuse Deterrent Pharma, Llc Common Stock
Jun 09, 2021 Buy 42 984 375 Schutte John Common Stock
May 25, 2021 Buy 66 666 Thangaraj Immanuel Restricted Stock Units (2021 Plan)
May 25, 2021 Buy 66 666 Skelly William G Restricted Stock Units (2021 Plan)
Show all Insider Trades


Last 100 transactions
Buy: 99 268 128 | Sell: 7 967 278 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.52 .
0.52 .
0.52 .
Current price: 0.52
Support 0.52 .
0.52 .
0.52 .

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.56 7.69 %
0.55 5.02 %
0.54 2.88 %
Current price 0.52
Support 0.52 -0.48%
0.51 -1.92%
0.50 -3.85%

Click to get the best stock tips daily for free!

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and aller... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE